Skip Navigation



The European Journal of Public Health Advance Access published online on August 26, 2005
The European Journal of Public Health, doi:10.1093/eurpub/cki053
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
15/6/621    most recent
cki053v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Andersson, K.
Right arrow Articles by Nilsson, J. L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, K.
Right arrow Articles by Nilsson, J. L. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.
Received May 14, 2004
Accepted September 6, 2004

Article

Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication

Kristin Andersson 1, Arne Melander 2, Carin Svensson 3, Owe Lind 4, and J. Lars G. Nilsson 1*

1 NEPI Foundation, Stockholm, Sweden
2 NEPI Foundation, Stockholm, Sweden; Department of Community Medicine, Malmö University Hospital, Malmö, Sweden
3 Qulturum Pharmacy, Ryhov Hospital, Jönköping, Sweden
4 Jönköping County Council, Jönköping, Sweden

* To whom correspondence should be addressed.
J. Lars G. Nilsson, E-mail: lars.nilsson{at}nepi.net


  Abstract

Background: Repeat prescribing used in long-term pharmacotherapy is often associated with inadequate patient medication, including non-adherence. In this paper we explore patients' drug refill adherence with repeat prescriptions and relate refill data to patient age and gender, type of prescriber, type of prescribed drug, and reimbursement level. Methods: During one week of 2002, copies of 3636 repeat prescriptions filled at 16 large Swedish pharmacies were collected. Satisfactory refill adherence was defined as dispensed refills covering 80-120% of the prescribed treatment time. Under- and oversupplying were defined as <80% and >120% coverage, respectively. Results: The average level of refill adherence was 57%, and the level of under- and oversupplying 21% and 22%, respectively. There was no gender difference. Patients who were exempt from payment had higher oversupplies than others (33% versus 19%), and patients of general practitioners had higher refill adherence than patients of hospital physicians. The highest refill adherence was observed for contraceptives (81%) and the lowest for anti-asthmatics, proton pump inhibitors and non-steroidal anti-inflammatory drugs (30-40%). Conclusions: Refill non-adherence includes both under- and oversupplying and may vary due to different attitudes between prescribers and between patients. Different therapeutic indications and reimbursement systems are other apparent causes. These observations should be considered in programs aiming to assist patients in following medication prescriptions.

Keywords: oversupply; refill adherence; repeat prescriptions; undersupply.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. A. Chambers, R. Raine, A. Rahman, and D. Isenberg
Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort
Rheumatology, March 1, 2009; 48(3): 266 - 271.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
L. T. Westerlund and H T. Bjork
Pharmaceutical Care in Community Pharmacies: Practice and Research in Sweden
Ann. Pharmacother., June 1, 2006; 40(6): 1162 - 1169.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.